S. Shirakawa, A. Moriyama, S. Shimizu
FULL PAPER
H), 6.28–6.39 (m, 4 H), 4.45 (d, J = 13.4 Hz, 1 H), 4.43 (d, J = 3.08 (d, J = 13.3 Hz, 1 H), 3.07 (d, J = 13.4 Hz, 1 H), 2.33 (q, J =
13.3 Hz, 1 H), 4.39 (d, J = 13.4 Hz, 1 H), 4.37 (d, J = 13.3 Hz, 1
6.9 Hz, 2 H), 1.87–1.97 (m, 8 H), 0.92–1.08 (m, 15 H) ppm. 13C
H), 3.86–3.95 (m, 4 H), 3.70–3.77 (m, 4 H), 3.43 (s, 2 H), 3.16 (d, NMR (100 MHz, CDCl3): δ = 156.67, 156.25, 155.73, 155.54,
J = 13.4 Hz, 1 H), 3.14 (d, J = 13.4 Hz, 1 H), 3.08 (d, J = 13.5 Hz, 144.64, 137.27, 137.24, 135.47, 135.12, 134.82, 134.77, 134.42,
1 H), 3.07 (d, J = 13.4 Hz, 1 H), 2.37 (t, J = 7.4 Hz, 4 H), 1.84– 134.10, 132.32, 130.63, 130.50, 128.97, 128.84, 128.66, 128.53,
1.93 (m, 8 H), 1.43–1.50 (m, 4 H), 1.28–1.36 (m, 4 H), 1.02–1.07
128.43, 128.34, 128.02, 127.97, 127.93, 125.76, 125.06, 125.02,
(m, 6 H), 0.90–0.93 (m, 12 H) ppm. 13C NMR (100 MHz, CDCl3): 123.06, 122.14, 121.93, 120.35, 114.59, 76.87, 76.76, 76.65, 57.03,
δ = 157.38, 156.23, 155.66, 154.94, 136.53, 136.46, 136.43, 135.85, 56.97, 47.17, 30.97, 30.84, 23.26, 23.24, 23.17, 12.05, 10.39, 10.34,
135.42, 134.85, 134.02, 133.92, 132.73, 130.38, 130.20, 129.73, 10.26, 10.22 ppm. IR: ν = 2966, 2935, 2877, 1458, 1326, 1213, 1163,
˜
129.11, 128.98, 128.41, 127.59, 127.54, 122.21, 121.93, 114.78, 1125, 1067, 1006, 765 cm–1. C51H59BrF3NO4 (886.92): calcd. C
76.82, 76.70, 76.62, 76.58, 57.95, 53.46, 31.00, 30.95, 30.88, 30.84,
29.19, 23.41, 23.30, 23.07, 20.77, 14.22, 10.64, 10.57, 10.05,
69.06, H 6.71, N 1.58; found C 68.61, H 6.69, N 1.45.
5-[(Dibutylamino)methyl]-11-hydroxy-25,26,27,28-tetrapropoxycalix-
[4]arene [(؎)-1a]: nBuLi (8.0 mmol, 1.5 in hexane) was added to
a solution of 5a (4.0 mmol) in THF (100 mL) at –78 °C under ar-
gon, and the mixture was stirred at this temperature for 30 min.
B(OMe)3 (16 mmol) was added, and the mixture was stirred at
–78 °C for 1 h. Then 30% aq. H2O2 (15 mL) and 3 aq. NaOH
(15 mL) were added to the resulting reaction mixture, which was
warmed to room temperature. After stirring at room temperature
10.00 ppm. IR: ν = 2959, 2931, 2873, 1456, 1212, 1195, 1009,
˜
763 cm–1. C49H66BrNO4 (812.96): calcd. C 72.39, H 8.18, N 1.72;
found C 72.29, H 8.01, N 1.56.
5-{[(Benzyl)(ethyl)amino]methyl}-11-bromo-25,26,27,28-tetraprop-
oxycalix[4]arene [(؎)-5b]: Calix[4]arene 5b was prepared from 4b in
a manner similar to that described for 5a by using ethyl bromide
(3 equiv.) instead of n-butyl bromide (91 % yield). 1H NMR
(400 MHz, CDCl3): δ = 7.16–7.32 (m, 5 H), 6.45–6.76 (m, 10 H), for 1 h, the reaction was quenched with Na2S2O3·5H2O (32 mmol),
4.42 (d, J = 13.4 Hz, 1 H + 1 H), 4.38 (d, J = 13.4 Hz, 1 H + 1 and the mixture was stirred for 30 min. After removal of THF by
H), 3.76–3.88 (m, 8 H), 3.42 (s, 2 H), 3.33 (s, 2 H), 3.14 (d, J = evaporation, organic materials were extracted with CHCl3
13.3 Hz, 1 H), 3.13 (d, J = 13.4 Hz, 1 H), 3.07 (d, J = 13.3 Hz, 1 (50 mL ϫ 2). The organic extracts were washed with water and
H), 3.06 (d, J = 13.3 Hz, 1 H), 2.36 (q, J = 6.9 Hz, 2 H), 1.85–1.94 dried with MgSO4. Evaporation of solvents and purification of the
(m, 8 H), 0.92–1.05 (m, 15 H) ppm. 13C NMR (100 MHz, CDCl3): residue by column chromatography on silica gel (CHCl3/AcOEt =
δ = 156.78, 156.06, 155.71, 155.35, 140.05, 137.06, 136.99, 135.64, 1:1 as eluent) afforded 1a in 51 % yield (1.53 g). 1H NMR
135.15, 134.58, 134.52, 134.15, 132.75, 130.60, 130.37, 129.11, (400 MHz, CDCl3): δ = 6.76–6.86 (m, 4 H), 6.72 (t, J = 7.4 Hz, 1
128.80, 128.64, 128.56, 128.11, 128.08, 127.88, 127.81, 126.55, H), 6.45 (t, J = 7.4 Hz, 1 H), 6.36–6.38 (m, 2 H), 5.81 (s, 2 H), 4.45
122.17, 121.98, 114.65, 76.75, 76.72, 76.66, 76.62, 57.43, 57.00,
46.91, 30.95, 30.82, 23.28, 23.18, 23.12, 11.98, 10.45, 10.40, 10.21,
(d, J = 13.3 Hz, 1 H), 4.43 (d, J = 13.7 Hz, 1 H), 4.40 (d, J =
13.7 Hz, 1 H), 4.37 (d, J = 13.2 Hz, 1 H), 3.86–3.92 (m, 4 H), 3.77
(t, J = 7.1 Hz, 2 H), 3.69 (t, J = 7.1 Hz, 2 H), 3.39 (s, 2 H), 3.15
(d, J = 13.3 Hz, 1 H), 3.13 (d, J = 13.3 Hz, 1 H), 3.06 (d, J =
12.8 Hz, 1 H), 3.03 (d, J = 12.8 Hz, 1 H), 2.32 (t, J = 7.5 Hz, 4 H),
1.87–1.93 (m, 8 H), 1.41–1.47 (m, 4 H), 1.25–1.32 (m, 4 H), 1.01–
1.06 (m, 6 H), 0.88–0.94 (m, 12 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 156.87, 156.30, 156.01, 150.79, 149.74, 135.43, 135.38,
135.33, 134.93, 134.87, 134.82, 130.40, 129.56, 129.50, 128.23,
128.22, 128.00, 127.92, 121.86, 121.74, 114.80, 76.74, 76.70, 76.66,
57.30, 52.81, 31.10, 31.07, 31.00, 28.39, 23.27, 23.20, 20.73, 14.15,
10.17 ppm. IR: ν = 2966, 2876, 1458, 1213, 1009, 964, 763,
˜
738 cm–1. C50H60BrNO4·0.1CHCl3 (818.92·0.1CHCl3): calcd. C
72.43, H 7.28, N 1.69; found C 72.18, H 7.28, N 1.63.
5-Bromo-11-{[(ethyl)(4-methoxybenzyl)amino]methyl}-25,26,27,28-
tetrapropoxycalix[4]arene [(؎)-5c]: Calix[4]arene 5c was prepared
from 4c in a manner similar to that described for 5a by using ethyl
bromide (3 equiv.) instead of n-butyl bromide (95 % yield). 1H
NMR (400 MHz, CDCl3): δ = 7.19 (d, J = 8.6 Hz, 2 H), 6.87 (d,
J = 8.6 Hz, 2 H), 6.45–6.75 (m, 10 H), 4.43 (d, J = 13.4 Hz, 1 H),
4.42 (d, J = 13.3 Hz, 1 H), 4.385 (d, J = 13.5 Hz, 1 H), 4.380 (d, J
= 13.3 Hz, 1 H), 3.77–3.87 (m, 8 H), 3.80 (s, 3 H), 3.36 (s, 2 H),
3.33 (s, 2 H), 3.14 (d, J = 13.5 Hz, 1 H + 1 H), 3.08 (d, J = 13.4 Hz,
1 H), 3.07 (d, J = 13.5 Hz, 1 H), 2.35 (q, J = 7.0 Hz, 2 H), 1.85–
1.96 (m, 8 H), 0.99–1.07 (m, 9 H), 0.90–0.97 (m, 6 H) ppm. 13C
10.45, 10.41, 10.28, 10.24 ppm. IR: ν = 3386, 2961, 2932, 2874,
˜
1592, 1466, 1212, 1006, 763 cm–1. C49H67NO5 (750.06): calcd. C
78.46, H 9.00, N 1.87; found C 78.14, H 8.85, N 1.72.
5-{[(Benzyl)(ethyl)amino]methyl}-11-hydroxy-25,26,27,28-tetraprop-
oxycalix[4]arene [(؎)-1b]: Calix[4]arene 1b was prepared from 5b in
NMR (100 MHz, CDCl3): δ = 158.36, 156.81, 156.09, 155.73, a manner similar to that described for 1a (48% yield). 1H NMR
155.37, 137.10, 137.02, 135.67, 135.17, 134.63, 134.61, 134.55, (400 MHz, CDCl3): δ = 7.20–7.33 (m, 5 H), 6.74 (s, 1 H), 6.71 (s,
134.17, 132.80, 131.92, 130.60, 130.38, 129.95, 129.16, 128.66, 1 H), 6.62–6.64 (m, 2 H), 6.51–6.53 (m, 3 H), 6.44 (t, J = 7.4 Hz,
128.58, 128.13, 127.89, 127.82, 122.17, 122.01, 114.64, 113.48, 1 H), 5.91–5.94 (m, 2 H), 4.43 (d, J = 13.2 Hz, 1 H + 1 H), 4.37
76.77, 76.74, 76.69, 76.65, 56.81, 56.66, 55.23, 46.73, 30.96, 30.85,
(d, J = 13.2 Hz, 1 H + 1 H), 3.80–3.84 (m, 6 H), 3.74 (t, J = 7.3 Hz,
2 H), 3.28–3.42 (m, 4 H), 3.13 (d, J = 13.2 Hz, 1 H), 3.12 (d, J =
13.3 Hz, 1 H), 3.03 (d, J = 13.2 Hz, 1 H), 3.02 (d, J = 13.3 Hz, 1
H), 2.32–2.38 (m, 2 H), 1.87–1.95 (m, 8 H), 0.93–1.04 (m, 15 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 156.78, 156.26, 155.80,
150.17, 149.95, 139.89, 135.66, 135.59, 135.38, 135.11, 134.93,
134.78, 134.74, 132.12, 129.00, 128.82, 128.67, 128.23, 128.14,
127.94, 126.66, 121.79, 114.52, 114.47, 76.76, 76.68, 76.65, 57.07,
56.99, 47.08, 31.02, 30.95, 23.25, 23.21, 23.18, 23.16, 11.81, 10.44,
23.29, 23.18, 23.13, 11.94, 10.46, 10.40, 10.21, 10.17 ppm. IR: ν =
˜
2965, 2934, 2876, 1512, 1457, 1248, 1212, 1196, 1039, 1007, 966,
765 cm–1. C51H62BrNO5·0.1CHCl3 (848.95·0.1CHCl3): calcd. C
71.30, H 7.26, N 1.63; found C 71.22, H 7.27, N 1.62.
5-Bromo-11-({(ethyl)[4-(trifluoromethyl)benzyl]amino}methyl)-
25,26,27,28-tetrapropoxycalix[4]arene [(؎)-5d]: Calix[4]arene 5d
was prepared from 4d in a manner similar to that described for 5a
by using ethyl bromide (3 equiv.) instead of n-butyl bromide (80%
yield). 1H NMR (400 MHz, CDCl3): δ = 7.58 (d, J = 8.0 Hz, 2 H),
7.39 (d, J = 7.9 Hz, 2 H), 6.51–6.70 (m, 9 H), 6.42 (t, J = 7.4 Hz,
1 H), 4.43 (d, J = 14.0 Hz, 1 H + 1 H), 4.39 (d, J = 13.6 Hz, 1 H),
4.38 (d, J = 13.6 Hz, 1 H), 3.76–3.87 (m, 8 H), 3.41 (s, 2 H), 3.30
(s, 2 H), 3.15 (d, J = 13.3 Hz, 1 H), 3.14 (d, J = 13.4 Hz, 1 H),
10.41, 10.25, 10.21 ppm. IR: ν = 3537, 2964, 2934, 2876, 1457,
˜
1214, 1008, 967, 766 cm–1. C50H61NO5 (756.02): calcd. C 79.43, H
8.13, N 1.85; found C 78.99, H 8.11, N 1.77.
5-{[(Ethyl)(4-methoxybenzyl)amino]methyl}-11-hydroxy-25,26,27,28-
tetrapropoxycalix[4]arene [(؎)-1c]: Calix[4]arene 1c was prepared
5962
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 5957–5964